Susanne Vrtala

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gangl K; Reininger R; Bernhard D; Campana R; Pree I; Reisinger J; Kneidinger M; Kundi M; Dolznig H; Thurnher D; Valent P; Chen K-W; Vrtala S; Spitzauer S; Valenta R; Niederberger V
Cigarette smoke facilitates allergen penetration across respiratory epithelium.
Weghofer M; Thomas W R; Kronqvist M; Mari A; Purohit A; Pauli G; Horak F; Grönlund H; van Hage M; Valenta R; Vrtala S
Variability of IgE reactivity profiles among European mite allergic patients.
Linhart Birgit; Mothes-Luksch Nadine; Vrtala Susanne; Kneidinger Michael; Valent Peter; Valenta Rudolf
A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Susanne Vrtala (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gangl K; Reininger R; Bernhard D; Campana R; Pree I; Reisinger J; Kneidinger M; Kundi M; Dolznig H; Thurnher D; Valent P; Chen K-W; Vrtala S; Spitzauer S; Valenta R; Niederberger V
Cigarette smoke facilitates allergen penetration across respiratory epithelium.
Allergy 2009;64(3):398-405.
2008: Weghofer M; Thomas W R; Kronqvist M; Mari A; Purohit A; Pauli G; Horak F; Grönlund H; van Hage M; Valenta R; Vrtala S
Variability of IgE reactivity profiles among European mite allergic patients.
European journal of clinical investigation 2008;38(12):959-65.
2008: Linhart Birgit; Mothes-Luksch Nadine; Vrtala Susanne; Kneidinger Michael; Valent Peter; Valenta Rudolf
A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
Biological chemistry 2008;389(7):925-33.
2008: Weghofer M; Dall'Antonia Y; Grote M; Stöcklinger A; Kneidinger M; Balic N; Krauth M-T; Fernández-Caldas E; Thomas W R; van Hage M; Vieths S; Spitzauer S; Horak F; Svergun D I; Konarev P V; Valent P; Thalhamer J; Keller W; Valenta R; Vrtala S
Characterization of Der p 21, a new important allergen derived from the gut of house dust mites.
Allergy 2008;63(6):758-67.
2008: Chen Kuan-Wei; Fuchs Gudrun; Sonneck Karoline; Gieras Anna; Swoboda Ines; Douladiris Nikolas; Linhart Birgit; Jankovic Marija; Pavkov Tea; Keller Walter; Papadopoulos Nikolaos G; Valent Peter; Valenta Rudolf; Vrtala Susanne
Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.
Molecular immunology 2008;45(9):2486-98.
2008: Vrtala S
From allergen genes to new forms of allergy diagnosis and treatment.
Allergy 2008;63(3):299-309.
2008: Kneidinger Michael; Schmidt Uwe; Rix Uwe; Gleixner Karoline V; Vales Anja; Baumgartner Christian; Lupinek Christian; Weghofer Margit; Bennett Keiryn L; Herrmann Harald; Schebesta Alexandra; Thomas Wayne R; Vrtala Susanne; Valenta Rudolf; Lee Francis Y; Ellmeier Wilfried; Superti-Furga Giulio; Valent Peter
The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils.
Blood 2008;111(6):3097-107.
2008: Szalai Krisztina; Fuhrmann Jan; Pavkov Tea; Scheidl Michael; Wallmann Julia; Brämswig Kira H; Vrtala Susanne; Scheiner Otto; Keller Walter; Saint-Remy Jean-Marie; Neumann Dirk; Pali-Schöll Isabella; Jensen-Jarolim Erika
Mimotopes identify conformational B-cell epitopes on the two major house dust mite allergens Der p 1 and Der p 2.
Molecular immunology 2008;45(5):1308-17.
2008: Campana Raffaela; Mothes Nadine; Rauter Ingrid; Vrtala Susanne; Reininger Renate; Focke-Tejkl Margarete; Lupinek Christian; Balic Nadja; Spitzauer Susanne; Valenta Rudolf
Non-IgE-mediated chronic allergic skin inflammation revealed with rBet v 1 fragments.
The Journal of allergy and clinical immunology 2008;121(2):528-530.e1.
2008: Sonneck K; Baumgartner C; Rebuzzi L; Marth K; Chen K W; Hauswirth A W; Florian S; Vrtala S; Bühring H J; Valenta R; Valent P
Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients.
International journal of immunopathology and pharmacology 2008;21(1):11-21.
2008: Weghofer Margit; Grote Monika; Dall'Antonia Yuliya; Fernández-Caldas Enrique; Krauth Maria-Theresa; van Hage Marianne; Horak Friedrich; Thomas Wayne R; Valent Peter; Keller Walter; Valenta Rudolf; Vrtala Susanne
Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy.
International archives of allergy and immunology 2008;147(2):101-9.
2007: Pree Ines; Reisinger Jürgen; Focke Margit; Vrtala Susanne; Pauli Gabrielle; van Hage Marianne; Cromwell Oliver; Gadermaier Elisabeth; Egger Cornelia; Reider Norbert; Horak Friedrich; Valenta Rudolf; Niederberger Verena
Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(8):5309-16.
2007: Bussmann C; Maintz L; Hart J; Allam J-P; Vrtala S; Chen K-W; Bieber T; Thomas W R; Valenta R; Zuberbier T; Sager A; Novak N
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2007;37(9):1277-85.
2007: Vrtala Susanne; Focke Margarete; Kopec Jolanta; Verdino Petra; Hartl Arnulf; Sperr Wolfgang R; Fedorov Alexander A; Ball Tanja; Almo Steve; Valent Peter; Thalhamer Josef; Keller Walter; Valenta Rudolf
Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1730-9.
2007: Stern Debra A; Riedler Josef; Nowak Dennis; Braun-Fahrlander Charlotte; Swoboda Ines; Balic Nadja; Chen Kuan-Wei; Vrtala Susanne; Grönlund Hans; van Hage Marianne; Valenta Rudolf; Spitzauer Susanne; Von Mutius Erika; Vercelli Donata
Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants.
The Journal of allergy and clinical immunology 2007;119(2):351-8.
2006: Gabler Maximilian; Scheiblhofer Sandra; Kern Kerstin; Leitner Wolfgang W; Stoecklinger Angelika; Hauser-Kronberger Cornelia; Alinger Beate; Lechner Berta; Prinz Monika; Vrtala Susanne; Valenta Rudolf; Thalhamer Josef; Weiss Richard
Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization.
The Journal of allergy and clinical immunology 2006;118(3):734-41.
2006: Rauter Ingrid; Krauth Maria-Theresa; Flicker Sabine; Gieras Anna; Westritschnig Kerstin; Vrtala Susanne; Balic Nadja; Spitzauer Susanne; Huss-Marp Johannes; Brockow Knut; Darsow Ulf; Ring Johannes; Behrendt Heidrun; Semper Hans; Valent Peter; Valenta Rudolf
Allergen cleavage by effector cell-derived proteases regulates allergic inflammation.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(7):967-9.
2006: Winkler B; Hufnagl K; Spittler A; Ploder M; Kállay E; Vrtala S; Valenta R; Kundi M; Renz H; Wiedermann U
The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice.
Allergy 2006;61(2):173-80.
2006: Dehlink E; Eiwegger T; Gerstmayr M; Kampl E; Bohle B; Chen K-W; Vrtala S; Urbanek R; Szépfalusi Z
Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2006;36(1):32-9.
2005: Weghofer M; Thomas W R; Pittner G; Horak F; Valenta R; Vrtala S
Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2005;35(10):1384-91.
2005: Sellge G; Laffer S; Mierke C; Vrtala S; Hoffmann M W; Klempnauer J; Manns M P; Valenta R; Bischoff S C
Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin E and immunoglobulin G: Fcepsilon receptor I supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type I allergic reactions.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2005;35(6):774-81.
2004: Niederberger V; Horak F; Vrtala S; Spitzauer S; Krauth M-T; Valent P; Reisinger J; Pelzmann M; Hayek B; Kronqvist M; Gafvelin G; Grönlund H; Purohit A; Suck R; Fiebig H; Cromwell O; Pauli G; van Hage-Hamsten M; Valenta R
Vaccination with genetically engineered allergens prevents progression of allergic disease.
Proceedings of the National Academy of Sciences of the United States of America 2004;101 Suppl 2():14677-82.
2004: Pittner G; Vrtala S; Thomas W R; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(4):597-603.
2004: Vrtala Susanne; Focke-Tejkl Margarete; Swoboda Ines; Kraft Dietrich; Valenta Rudolf
Strategies for converting allergens into hypoallergenic vaccine candidates.
Methods (San Diego, Calif.) 2004;32(3):313-20.
2004: Mahler V; Vrtala S; Kuss O; Diepgen T L; Suck R; Cromwell O; Fiebig H; Hartl A; Thalhamer J; Schuler G; Kraft D; Valenta R
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(1):115-22.
2004: Valenta R; Ball T; Focke M; Linhart B; Mothes N; Niederberger V; Spitzauer S; Swoboda I; Vrtala S; Westritschnig K; Kraft D
Immunotherapy of allergic disease.
Advances in immunology 2004;82():105-53.
2003: Hochreiter Romana; Stepanoska Tatjana; Ferreira Fatima; Valenta Rudolf; Vrtala Susanne; Thalhamer Josef; Hartl Arnulf
Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
European journal of immunology 2003;33(6):1667-76.
2003: Westritschnig K; Sibanda E; Thomas W; Auer H; Aspöck H; Pittner G; Vrtala S; Spitzauer S; Kraft D; Valenta R
Analysis of the sensitization profile towards allergens in central Africa.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2003;33(1):22-7.
2002: Grönlund Hans; Vrtala Susanne; Wiedermann Ursula; Dekan Gerhard; Kraft Dietrich; Valenta Rudolf; Van Hage-Hamsten Marianne
Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy.
Immunology 2002;107(4):523-9.
2002: van Hage-Hamsten M; Johansson E; Roquet A; Peterson C; Andersson M; Greiff L; Vrtala S; Valenta R; Grönneberg R
Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(10):1448-53.
2002: Maglio Ornella; Saldanha Jose W; Vrtala Susanne; Spitzauer Susanne; Valenta Rudolf; Pastore Annalisa
A major IgE epitope-containing grass pollen allergen domain from Phl p 5 folds as a four-helix bundle.
Protein engineering 2002;15(8):635-42.
2002: Valenta Rudolf; Vrtala Susanne; Focke-Tejkl Margit; Twardosz Anna; Swoboda Ines; Bugajska-Schretter Agnes; Spitzauer Susanne; Kraft Dietrich
Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
Clinical allergy and immunology 2002;16():495-517.
2001: Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
International archives of allergy and immunology 2001;126(1):68-77.
2001: Vrtala S; Hirtenlehner K; Susani M; Akdis M; Kussebi F; Akdis C A; Blaser K; Hufnagl P; Binder B R; Politou A; Pastore A; Vangelista L; Sperr W R; Semper H; Valent P; Ebner C; Kraft D; Valenta R
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(11):2045-7.
2001: Grote M; Vrtala S; Niederberger V; Wiermann R; Valenta R; Reichelt R
Release of allergen-bearing cytoplasm from hydrated pollen: a mechanism common to a variety of grass (Poaceae) species revealed by electron microscopy.
The Journal of allergy and clinical immunology 2001;108(1):109-15.
2001: Wiedermann U; Herz U; Vrtala S; Neuhaus-Steinmetz U; Renz H; Ebner C; Valenta R; Kraft D
Mucosal tolerance induction with hypoallergenic molecules in a murine model of allergic asthma.
International archives of allergy and immunology 2001;124(1-3):391-4.
2000: Vrtala S; Akdis C A; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(11):6653-9.
2000: Flicker S; Vrtala S; Steinberger P; Vangelista L; Bufe A; Petersen A; Ghannadan M; Sperr W R; Valent P; Norderhaug L; Bohle B; Stockinger H; Suphioglu C; Ong E K; Kraft D; Valenta R
A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):3849-59.
2000: Pauli G; Purohit A; Oster J P; De Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2000;30(8):1076-84.
2000: Nopp A; Halldén G; Lundahl J; Johansson E; Vrtala S; Valenta R; Grönneberg R; Van Hage-Hamsten M
Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen bet v 1 and to recombinant bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients.
The Journal of allergy and clinical immunology 2000;106(1 Pt 1):101-9.
2000: Grote M; Vrtala S; Niederberger V; Valenta R; Reichelt R
Expulsion of allergen-containing materials from hydrated rye grass (Lolium perenne) pollen revealed by using immunogold field emission scanning and transmission electron microscopy.
The Journal of allergy and clinical immunology 2000;105(6 Pt 1):1140-5.
2000: Aghayan-Ugurluoglu R; Ball T; Vrtala S; Schweiger C; Kraft D; Valenta R
Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens.
The Journal of allergy and clinical immunology 2000;105(4):803-13.
1999: Vrtala S; Fischer S; Grote M; Vangelista L; Pastore A; Sperr W R; Valent P; Reichelt R; Kraft D; Valenta R
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5489-96.
1999: van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
The Journal of allergy and clinical immunology 1999;104(5):969-77.
1999: Pandjaitan B; Eibensteiner P B; Vrtala S; Hayek B; Grote M; Reichelt R; Rumpold H; Valenta R; Spitzauer S
pET-prof, a plasmid for high-level expression of recombinant peptides fused to a birch profilin-derived hexadecapeptide tag: a system for the detection and presentation of recombinant antigens.
Gene 1999;237(2):333-42.
1999: De Marino S; Morelli M A; Fraternali F; Tamborini E; Musco G; Vrtala S; Dolecek C; Arosio P; Valenta R; Pastore A
An immunoglobulin-like fold in a major plant allergen: the solution structure of Phl p 2 from timothy grass pollen.
Structure (London, England : 1993) 1999;7(8):943-52.
1999: Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
Biological chemistry 1999;380(7-8):815-24.
1999: Niederberger V; Hayek B; Vrtala S; Laffer S; Twardosz A; Vangelista L; Sperr W R; Valent P; Rumpold H; Kraft D; Ehrenberger K; Valenta R; Spitzauer S
Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1999;13(8):843-56.
1999: Vrtala S; Hirtenlehner K; Susani M; Hufnagl P; Binder B R; Vangelista L; Pastore A; Sperr W R; Valent P; Ebner C; Kraft D; Valenta R
Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
International archives of allergy and immunology 1999;118(2-4):218-9.
1999: Pauli G; Purohit A; Oster J P; de Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
Clinical evaluation of genetically engineered hypoallergenic rBet v 1 derivatives.
International archives of allergy and immunology 1999;118(2-4):216-7.
1999: Kraft D; Ferreira F; Vrtala S; Breiteneder H; Ebner C; Valenta R; Susani M; Breitenbach M; Scheiner O
The importance of recombinant allergens for diagnosis and therapy of IgE-mediated allergies.
International archives of allergy and immunology 1999;118(2-4):171-6.
1999: Valenta R; Twardosz A; Vrtala S; Kraft D
Large scale production and quality criteria of recombinant allergens.
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe) zu Frankfurt a.M 1999;(93):211-24; discussion 224-5.
1999: Pauli G; Purohit A; Oster J P; de Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
Skin testing with wild-type recombinant birch pollen allergens and hypoallergenic modified molecules.
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe) zu Frankfurt a.M 1999;(93):203-10.
1998: Hayek B; Vangelista L; Pastore A; Sperr W R; Valent P; Vrtala S; Niederberger V; Twardosz A; Kraft D; Valenta R
Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):7031-9.
1998: Valenta R; Almo S; Ball T; Dolecek C; Steinberger P; Laffer S; Eibensteiner P; Flicker S; Vrtala S; Spitzauer S; Valent P; Denepoux S; Kraft D; Banchereau J; Lebecque S
The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases.
International archives of allergy and immunology 1998;116(3):167-76.
1998: Valenta R; Vrtala S; Laffer S; Spitzauer S; Kraft D
Recombinant allergens.
Allergy 1998;53(6):552-61.
1998: Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr W R; Valent P; Kraft D; Valenta R
Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):6137-44.
1997: Vrtala S; Hirtenlehner K; Vangelista L; Pastore A; Eichler H G; Sperr W R; Valent P; Ebner C; Kraft D; Valenta R
Division of the major birch pollen allergen, Bet v 1, into two non-anaphylactic fragments.
International archives of allergy and immunology 1997;113(1-3):246-8.
1997: Vrtala S; Hirtenlehner K; Vangelista L; Pastore A; Eichler H G; Sperr W R; Valent P; Ebner C; Kraft D; Valenta R
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy.
The Journal of clinical investigation 1997;99(7):1673-81.
1996: Vrtala S; Mayer P; Ferreira F; Susani M; Sehon A H; Kraft D; Valenta R
Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
The Journal of allergy and clinical immunology 1996;98(5 Pt 1):913-21.
1996: Vrtala S; Wiedemann P; Mittermann I; Eichler H G; Sperr W R; Valent P; Kraft D; Valenta R
High-level expression in Escherichia coli and purification of recombinant plant profilins: comparison of IgE-binding capacity and allergenic activity.
Biochemical and biophysical research communications 1996;226(1):42-50.
1996: Vrtala S; Susani M; Sperr W R; Valent P; Laffer S; Dolecek C; Kraft D; Valenta R
Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p2, Phl p 5).
The Journal of allergy and clinical immunology 1996;97(3):781-7.
1996: Valenta R; Laffer S; Vrtala S; Grönlund H; Elfman L; Sperr W R; Valent P; Ferreira F; Mayer P; Liehl E; Heiss S; Steiner R; Eichler H G; Susani M; Kraft D
Recombinant allergens. Steps on the way to diagnosis and therapy of type I allergy.
Advances in experimental medicine and biology 1996;409():185-96.
1995: Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
International archives of allergy and immunology 1995;107(1-3):290-4.
1994: Ball T; Vrtala S; Sperr W R; Valent P; Susani M; Kraft D; Valenta R
Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction.
The Journal of biological chemistry 1994;269(45):28323-8.
1994: Laffer S; Valenta R; Vrtala S; Susani M; van Ree R; Kraft D; Scheiner O; Duchêne M
Complementary DNA cloning of the major allergen Phl p I from timothy grass (Phleum pratense); recombinant Phl p I inhibits IgE binding to group I allergens from eight different grass species.
The Journal of allergy and clinical immunology 1994;94(4):689-98.
1994: Laffer S; Vrtala S; Duchêne M; van Ree R; Kraft D; Scheiner O; Valenta R
IgE-binding capacity of recombinant timothy grass (Phleum pratense) pollen allergens.
The Journal of allergy and clinical immunology 1994;94(1):88-94.
1994: Valenta R; Ball T; Vrtala S; Duchêne M; Kraft D; Scheiner O
cDNA cloning and expression of timothy grass (Phleum pratense) pollen profilin in Escherichia coli: comparison with birch pollen profilin.
Biochemical and biophysical research communications 1994;199(1):106-18.
1994: Valenta R; Vrtala S; Laffer S; Steinberger P; Ball T; Ferreira F; Scheiner O; Kraft D
B-cell epitopes of allergens determined by recombinant techniques; use for diagnosis and therapy of type I allergy.
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe) zu Frankfurt a.M 1994;(87):235-46.
1993: Dolecek C; Vrtala S; Laffer S; Steinberger P; Kraft D; Scheiner O; Valenta R
Molecular characterization of Phl p II, a major timothy grass (Phleum pratense) pollen allergen.
FEBS letters 1993;335(3):299-304.
1993: Vrtala S; Sperr W R; Reimitzer I; van Ree R; Laffer S; Müller W D; Valent P; Lechner K; Rumpold H; Kraft D
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(9):4773-81.
1993: Valenta R; Ferreira F; Grote M; Swoboda I; Vrtala S; Duchêne M; Deviller P; Meagher R B; McKinney E; Heberle-Bors E
Identification of profilin as an actin-binding protein in higher plants.
The Journal of biological chemistry 1993;268(30):22777-81.
1993: Grote M; Vrtala S; Valenta R
Monitoring of two allergens, Bet v I and profilin, in dry and rehydrated birch pollen by immunogold electron microscopy and immunoblotting.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1993;41(5):745-50.
1993: Vrtala S; Grote M; Duchêne M; van Ree R; Kraft D; Scheiner O; Valenta R
Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity.
International archives of allergy and immunology 1993;102(2):160-9.
1993: Valenta R; Steinberger P; Vrtala S; Grote M; Laffer S; Sperr W R; Valent P; Kraft D; Scheiner O
[New concepts in therapy of type I allergic diseases]
Wiener klinische Wochenschrift 1993;105(23):682-6.
1992: Valenta R; Vrtala S; Ebner C; Kraft D; Scheiner O
Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens.
International archives of allergy and immunology 1992;97(4):287-94.
1991: Valenta R; Duchene M; Vrtala S; Birkner T; Ebner C; Hirschwehr R; Breitenbach M; Rumpold H; Scheiner O; Kraft D
Recombinant allergens for immunoblot diagnosis of tree-pollen allergy.
The Journal of allergy and clinical immunology 1991;88(6):889-94.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Susanne Vrtala

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Procedures

Physiology

Concepts & Ideas

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Susanne Vrtala (preview)

All Publications